Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine

Clinical Neurophysiology

Volumn 119, Issue 11, 2008, Pages 2608-2614

  Nekrassov, Vladimir ^a   Sitges, María ^b  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antiepileptic drugs; BAEPs; Experimental epilepsy; Guinea pig

Indexed keywords

4 AMINOPYRIDINE; CARBAMAZEPINE; VINPOCETINE;

ACUTE DRUG ADMINISTRATION; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY THRESHOLD; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EVOKED AUDITORY RESPONSE; GUINEA PIG; HEARING LOSS; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TREATMENT DURATION;

4-AMINOPYRIDINE; ACOUSTIC STIMULATION; ANIMALS; ANTICONVULSANTS; AUDITORY THRESHOLD; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EVOKED POTENTIALS, AUDITORY; GUINEA PIGS; HEARING LOSS; MALE; PSYCHOACOUSTICS; SEIZURES; TIME FACTORS; VINCA ALKALOIDS;

EID: 54149084727     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2008.08.009     Document Type: Article

References (33)

1. Ambrosio A.F., Silva A.P., Araujo I., Soares-da-Silva P., Carvalho A.P., and Carvalho C.M. Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels. Eur J Pharmacol 406 (2001) 191-201
2. Armon C., Brown E., Carwile S., Miller P., and Shin C. Sensorineural hearing loss: a reversible effect of valproic acid. Neurology 40 (1990) 1896-1898
3. Brückner C., and Heinemann U. Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res 859 (2000) 15-20
4. Brunbech L., and Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs 62 (2002) 593-604
5. De la Cruz M., and Bance M. Carbamazepine-induced sensironeural hearing loss. Arch Otolaryngol Head Neck Surg 125 (1999) 225-227
6. Fueta Y., and Avoli M. Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus. Epilepsy Res 12 (1992) 207-215
7. Hirose G., Chujo T., Kataoka S., Kawada J., and Yoshioka A. Acute effects of anticonvulsants on brain-stem auditory evoked potentials in rats. Electroencephalogr Clin Neurophysiol 75 (1990) 543-547
8. Japaridze G., Kvernadze D., Geladze T., and Kevanishvili Z. Effects of carbamazepine on auditory brainstem response, middle-latency response, and slow cortical potential in epileptic patients. Epilepsia 34 (1993) 1105-1109
9. Kwan P., and Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357 (2001) 216-222
10. Lees G., Stöhr T., and Errington A. Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro. Neuropharmacology 50 (2006) 98-110
11. Macdonald R.L., and Barker J.L. Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 267 (1977) 720-721
12. Medaglini S., Filippi M., Smirne L., Ferini-Strambi L., Giusti M.C., Poggi A., et al. Effects of long-lasting antiepileptic therapy on brainstem auditory evoked potentials. Neuropsychobiology 19 (1988) 104-107
13. Mervaala E., Keränen T., Tihonen P., and Riekkinen P. The effects of carbamazepine and sodium valproate on SEPs and BAEPs. Electroencephalogr Clin Neurophysiol 68 (1987) 475-478
14. Morales-Villagran A., and Tapia R. Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. Neurochem Int 28 (1996) 35-40
15. Nekrassov V., and Sitges M. Vinpocetine protects from aminoglycoside antibiotic-induced hearing loss in guinea pig in vivo. Brain Res 868 (2000) 222-229
16. Nekrassov V., and Sitges M. Effects of pentylenetetrazole and 4-aminopyridine on the auditory brainstem response (ABR) and on the hearing sensitivity in the guinea pig in vivo. Epilepsy Res 53 (2003) 245-254
17. Nekrassov V., and Sitges M. Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo. Epilepsy Res 60 (2004) 63-71
18. Nekrassov V., and Sitges M. Additive effects of antiepileptic drugs and pentylenetetrazole on hearing. Neurosci Lett 406 (2006) 276-280
19. Prevey M.L., Delaney R.C., Cramer J.A., and Mattson R.H. Complex partial and secondarily generalized seizure patients: cognitive functioning prior to treatment with antiepileptic medication. VA Epilepsy Cooperative Study 264 Group. Epilepsy Res 30 (1998) 1-9
20. Rodin E., Chayasirisobhon S., and Klutke G. Brainstem auditory evoked potential recording in patients with epilepsy. Clin Electroencephalogr 13 (1982) 154-161
21. Rysz A., and Gajkowski K. Effect of phenytoin and carbamazepine on evoked potentials in patients with newly diagnosed epilepsy. Part II. Brainstem auditory evoked potentials. Neurol Neurochir Pol 30 (1996) 971-979
22. Schmidt D. The clinical impact of new antiepileptic drugs after a decade of use in epilepsy. Epilepsy Res 50 (2002) 21-32
23. Sitges M., Galvan E., and Nekrassov V. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes. Neurochem Int 46 (2005) 533-540
24. Sitges M., and Nekrassov V. Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. Clin Neurophysiol 115 (2004) 2711-2717
25. Sitges M., and Nekrassov V. Acute and chronic effects of carbamazepine, phenytoin, valproate and vinpocetine on BAEP parameters and threshold in the guinea pig. Clin Neurophysiol 118 (2007) 420-426
26. + channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 52 (2007) 598-605
27. + channel-mediated release. Neuropharmacology 53 (2007) 854-862
28. Soliman S., Mostafa M., Kamal N., Raafat M., and Hazzaa N. Auditory evoked potentials in epileptic patients. Ear Hear 14 (1993) 235-241
29. van der Meyden C.H., Bartel P.R., Sommers D.K., Blom M., Becker P., Erasmus S., et al. Effect of acute doses of controlled-release carbamazepine on clinical, psychomotor, electrophysiological, and cognitive parameters of brain function. Epilepsia 33 (1992) 335-342
30. Verrotti A., Trotta D., Cutarella R., Pascarella R., Morgese G., and Chiarelli F. Effects of antiepileptic drugs on evoked potentials in epileptic children. Pediatr Neurol 23 (2000) 397-402
31. Wakamoto H., Kume A., and Nakano N. Elevated pitch perception owing to carbamazepine-activating effect on the peripheral auditory system: auditory brainstem response study. J Child Neurol 19 (2004) 453-455
32. Yonekawa W., Kapetanovic I., and Kupferberg H. The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro. Epilepsy Res 20 (1995) 137-150
33. Yuksel A., Senocak D., Sozuer D., Keskin G., Dirican A., Cenani A., et al. Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. Childs Nerv Syst 11 (1995) 474-477